CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-07 | Myles Edward H COO & CFO | Sale 10b5-1 | −37,206 | $26.83 | $998K | 218,150 |
| 2024-10-07 | Myles Edward H COO & CFO | Sale 10b5-1 | −25,812 | $27.27 | $704K | 192,338 |
| 2024-10-07 | Myles Edward H COO & CFO | Sale 10b5-1 | −31,250 | $29.05 | $908K | 161,088 |
| 2024-10-07 | Myles Edward H COO & CFO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −165,810 | 0 | ||
| 2024-10-07 | Sacco Tracey CHIEF COMMERCIAL OFFICER | Exercise or conversion 10b5-1 | +30,000 | $10.00 | $300K | 79,285 |
| 2024-10-07 | Sacco Tracey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −28,036 | $25.58 | $717K | 51,249 |
| 2024-10-07 | Sacco Tracey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −1,964 | $26.23 | $52K | 49,285 |
| 2024-10-07 | Sacco Tracey CHIEF COMMERCIAL OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | +30,000 | 140,625 | ||
| 2024-10-07 | Marantz Jing L. CHIEF MEDICAL OFFICER | Exercise or conversion 10b5-1 | +109,375 | $8.59 | $940K | 182,230 |
| 2024-10-07 | Marantz Jing L. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −67,448 | $25.59 | $1.7M | 114,782 |
| 2024-10-07 | Marantz Jing L. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,552 | $26.22 | $67K | 112,230 |
| 2024-10-07 | Marantz Jing L. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −39,375 | $30.06 | $1.2M | 72,855 |
| 2024-10-07 | Marantz Jing L. CHIEF MEDICAL OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −109,375 | 140,625 | ||
| 2024-09-16 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | −1,936 | $8.58 | $17K | 142,768 |
| 2024-08-16 | Parlavecchio Caryn CHRO | Sale | −1,451 | $9.33 | $14K | 151,988 |
| 2024-06-27 | Burow Kristina Director | Grant or award | +13,500 | 18,839 | ||
| 2024-06-27 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2024-06-27 | Vaishnaw Akshay Director | Grant or award | +13,500 | 22,955 | ||
| 2024-06-27 | Vaishnaw Akshay Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2024-06-27 | Reed Joshua Director | Grant or award | +13,500 | 13,500 |
Page 14 of 22 · 422 trades